Food and Drug Administration – Page 33

Abortion Ruling Could Undermine the F.D.A.’s Drug-Approval Authority

Legal scholars say the ruling by a Texas judge, if upheld, could spur disputes over many medications and upend the drug industry’s reliance on the agency.

By Christina Jewett and Pam Belluck

Decisions and Verdicts Food and Drug Administration Kacsmaryk, Matthew Mifeprex (RU-486) Regulation and Deregulation of Industry Rice, Thomas O Roe v Wade (Supreme Court Decision) States (US) Suits and Litigation (Civil) United States

What’s Going On With the Abortion Pill Rulings by Federal Judges?

One invalidated the F.D.A.’s approval of the abortion pill mifepristone. The other ordered the F.D.A. to do nothing to restrict the pill’s availability.

By Pam Belluck

Courts and the Judiciary Food and Drug Administration Kacsmaryk, Matthew Suits and Litigation (Civil)

Texas Judge Invalidates FDA Approval of the Abortion Pill Mifepristone

The Texas judge’s ruling was quickly contradicted by another federal judge in Washington State who ordered the F.D.A. to keep mifepristone available.

By Pam Belluck

Drug Abuse and Traffic Drugs (Pharmaceuticals) Drugstores Emergent BioSolutions Inc Food and Drug Administration Naloxone (Drug) Opioids and Opiates

Over-the-Counter Narcan Could Save More Lives. But Price and Stigma Are Obstacles

The Food and Drug Administration is expected this week to allow the overdose-reversal medication to be sold without a prescription, a step toward making it a common emergency tool.

By Jan Hoffman

mosaec